Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3839261

Cl.NCC(=O)OCC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KCNH2 known ✓ Q12809 1/20 0.35
KIF11 P52732 11/20 0.41
MAPK1 P28482 2/20 0.39
HIF1A Q16665 2/20 0.38
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
RECQL P46063 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
KCNN4 O15554 1/20 0.35
CYP2C19 P33261 1/20 0.35
IDO1 P14902 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1249575 0.82 HIF1A (0.38) KIF11MAPK1HIF1ACYP1A2CYP3A4
SCHEMBL7565230 0.80 HIF1A (0.39) KIF11MAPK1HIF1ACYP1A2KCNN4
SCHEMBL5846764 0.79 HIF1A (0.44) KIF11MAPK1HIF1ACYP1A2MAPT
SCHEMBL11518543 0.76 HIF1A (0.36) KIF11MAPK1HIF1ACYP1A2CYP3A4
SCHEMBL9601801 0.76 HIF1A (0.41) KIF11MAPK1HIF1ACYP1A2MAPT
SCHEMBL9189254 0.76 ALDH1A1 (0.52) KIF11MAPK1HIF1AMAPTKMT2A
Hydrochloric Acid SCHEMBL1535932 0.74 HIF1A (0.38) KIF11MAPK1HIF1AMAPTKMT2A
Hydrochloric Acid SCHEMBL3839259 0.74 KCNN4 (0.42) HIF1ACYP1A2KMT2AKCNN4CYP2C19
SCHEMBL3950448 0.72 KIF11 (0.47) KIF11MAPK1HIF1ACYP1A2CYP3A4
SCHEMBL10520172 0.72 MAPT (0.44) KIF11MAPK1HIF1ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5658671-A ARTICLE COATED WITH COMPOSITION COMPRISING FLUOROELASTOMER, QUATERNARY AMMONIUM OR PHOSPHONIUM ACCELERATOR, POLYOL, ACID ACCEPTOR, OIL-SOLUBLE CHELATING AGENT, ORGANIC SOLVENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-19 US claimed
US-5451625-A FOR USE IN THE PREPARATION OF AUTOMOTIVE GASKETS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-19 US claimed
EP-0574319-A1 Fluoroelastomer coating composition MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-12-15 EP claimed
EP-1682609-B1 METHOD OF MODIFYING A FLUOROPOLYMER AND ARTICLES THEREBY 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
EP-2014703-B1 Process of preparing a composite article 3M INNOVATIVE PROPERTIES CO (US) 2009-12-09 EP disclosed
EP-2014703-A1 Method of modifying a fluoropolymer and articles thereby 3M Innovative Properties Company (US) 2009-01-14 EP disclosed
EP-1453896-B1 PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES CO (US) 2008-04-09 EP disclosed
EP-1461376-B1 IMPROVED PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES CO (US) 2006-12-20 EP disclosed
US-7140413-B2 Method of modifying a fluoropolymer and articles thereby 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-11-28 US disclosed
EP-1682609-A1 METHOD OF MODIFYING A FLUOROPOLYMER AND ARTICLES THEREBY 3M Innovative Properties Company (US) 2006-07-26 EP disclosed
US-20060029812-A1 Method of modifying a fluoropolymer and articles thereby 3M INNOVATIVE PROPERTIES COMPANY 2006-02-09 US disclosed
US-6752894-B2 EXPOSURE TO ACTINIC RADIATION; DISCOLORATION INHIBITION; OXIDATION RESISTANCE 3M INNOVATIVE PROPERTIES COMPANY 2004-06-22 US disclosed
US-20030159915-A1 Process for modifying a polymeric surface 3M INNOVATIVE PROPERTIES COMPANY 2003-08-28 US disclosed
US-20030162022-A1 Process for modifying a polymeric surface 3M INNOVATIVE PROPERTIES COMPANY 2003-08-28 US disclosed
WO-2003051966-A1 IMPROVED PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-26 WO disclosed
WO-2003051965-A1 PROCESS FOR MODIFYING A POLYMERIC SURFACE 3M INNOVATIVE PROPERTIES COMPANY (US) 2003-06-26 WO disclosed
EP-0574319-B1 Fluoroelastomer coating composition DYNEON LLC (US) 1998-01-21 EP disclosed
US-5658671-A ARTICLE COATED WITH COMPOSITION COMPRISING FLUOROELASTOMER, QUATERNARY AMMONIUM OR PHOSPHONIUM ACCELERATOR, POLYOL, ACID ACCEPTOR, OIL-SOLUBLE CHELATING AGENT, ORGANIC SOLVENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-08-19 US disclosed
US-5451625-A FOR USE IN THE PREPARATION OF AUTOMOTIVE GASKETS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-09-19 US disclosed
EP-0574319-A1 Fluoroelastomer coating composition MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-12-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030159915-A1 Process for modifying a polymeric surface FSCN1, FLNA, FLNB KCNH2 2913/4885KIF11 2037/4885MAPK1 3244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.